2019年度 Journal Club

Oncology

No.

日付

Title: Journal PMID.

担当者

まとめ

9 25th/Dec

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet2019 31838011 福田 石井
8 18th/Dec

Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development.

JMIR Research 28428158 石井 石井
7 27th/Nov

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.

JCO 2019  31682542 井部 石井
6 18th/Sept

 Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

Lancet2015 26045340 井部 石井
 5 17th/July

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Lancet 2019 31122901 高橋 石井
 4 26th/June

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

NEJM2019 30511879 飯尾 石井
 3 5th/June Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201). Lung Cancer 2019 31097051 福田 濱元
 2 3rd/April

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

 Lancet 2019 30799062

大越

石井
 1 10th/Apr

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial 

Lancet 2019

30922878 濱元 石井

COPD&Asthma

No.

日付

Title: Journal PMID.

担当者

まとめ

 1  8th/Jan  Metoprolol for the Prevention of Acute Exacerbations of COPD.                         NEJM2019  81633896   濵元  石井

Infection


Allergy

No.

日付

Title: Journal PMID

担当者

まとめ

1            

Other